Related Experiment Video
Updated: Aug 9, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
[Therapeutic effect of puerarin on rats with pre-eclampsia]
Chao Wang1, Xue-yan Wang, Shu Zhou
1Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, Chengdu 610041, China.
Zhonghua Fu Chan Ke Za Zhi
|April 28, 2006
Summary
Puerarin treatment in pre-eclampsia model rats significantly increased nitric oxide (NO) levels. This suggests puerarin may be a potential therapeutic agent for pre-eclampsia by improving NO concentration and reducing key symptoms.
Area of Science:
- Biomedical Science
- Pharmacology
Context:
- Pre-eclampsia is a pregnancy complication characterized by high blood pressure and organ damage.
- Nitric oxide (NO) plays a crucial role in regulating blood pressure and vascular function.
Purpose:
- To investigate the therapeutic potential of puerarin in a rat model of pre-eclampsia.
- To assess the effect of puerarin on nitric oxide (NO) levels in pre-eclamptic rats.
Summary:
- Puerarin administration to pre-eclampsia model rats led to a significant increase in plasma NO concentration.
- Treatment with puerarin also resulted in a significant reduction in both blood pressure and 24-hour urine protein levels.
- No significant changes in heart rate were observed in the puerarin-treated group compared to controls.
Impact:
- Puerarin demonstrates a therapeutic effect on pre-eclampsia in a rat model.
- The findings suggest that puerarin may be a viable treatment option for pre-eclampsia by modulating NO levels.
- Further research into puerarin's mechanism of action in pre-eclampsia is warranted.
